Corporate coalitions and policy making in the European Union

Katherine Elizabeth Smith, Gary Fooks, Anna B. Gilmore, Jeffrey Collin, Heide Weishaar

    Research output: Contribution to journalArticle

    15 Citations (Scopus)

    Abstract

    Over the past fifteen years, an inter-connected set of regulatory reforms, known as Better Regulation, has been adopted across Europe, marking a significant shift in the way European Union (EU) policies are developed. There has been little exploration of the origins of these reforms, which include mandatory ex-ante impact assessment. Drawing on documentary and interview data, this paper discusses how and why large corporations, notably British American Tobacco (BAT), worked to influence and promote these reforms. Our analysis highlights: (i) how policy entrepreneurs with sufficient resources (such as large corporations) can shape the membership and direction of advocacy coalitions; (ii) the extent to which ‘think tanks’ may be prepared to lobby on behalf of commercial clients; and (iii) why regulated industries (including tobacco) may favour the use of ‘evidence-tools’, such as impact assessments, in policymaking. We argue a key aspect of BAT’s ability to shape regulatory reform involved the deliberate construction of a vaguely defined idea that could be strategically adapted to appeal to diverse constituencies. We discuss the theoretical implications of this finding for the ‘Advocacy Coalition Framework’, as well as the practical implications of the findings for efforts to promote ‘transparency’ and public health in the EU.
    LanguageEnglish
    Pages325-372
    Number of pages48
    JournalJournal of Health Politics, Policy and Law
    Volume40
    Issue number2
    DOIs
    Publication statusPublished - 1 Apr 2015

    Fingerprint

    Policy Making
    European Union
    Tobacco
    coalition
    Tobacco Industry
    nicotine
    reform
    corporation
    Public Health
    Interviews
    think tank
    lobby
    entrepreneur
    transparency
    appeal
    public health
    regulation
    industry
    ability
    interview

    Keywords

    • better regulation
    • tobacco industry
    • corporate policy influence
    • evidence
    • British American Tobacco (BAT)
    • policy
    • industry regulation

    Cite this

    Smith, Katherine Elizabeth ; Fooks, Gary ; Gilmore, Anna B. ; Collin, Jeffrey ; Weishaar, Heide. / Corporate coalitions and policy making in the European Union. In: Journal of Health Politics, Policy and Law . 2015 ; Vol. 40, No. 2. pp. 325-372.
    @article{61330c7d8ac046688e7b373f8a399b10,
    title = "Corporate coalitions and policy making in the European Union",
    abstract = "Over the past fifteen years, an inter-connected set of regulatory reforms, known as Better Regulation, has been adopted across Europe, marking a significant shift in the way European Union (EU) policies are developed. There has been little exploration of the origins of these reforms, which include mandatory ex-ante impact assessment. Drawing on documentary and interview data, this paper discusses how and why large corporations, notably British American Tobacco (BAT), worked to influence and promote these reforms. Our analysis highlights: (i) how policy entrepreneurs with sufficient resources (such as large corporations) can shape the membership and direction of advocacy coalitions; (ii) the extent to which ‘think tanks’ may be prepared to lobby on behalf of commercial clients; and (iii) why regulated industries (including tobacco) may favour the use of ‘evidence-tools’, such as impact assessments, in policymaking. We argue a key aspect of BAT’s ability to shape regulatory reform involved the deliberate construction of a vaguely defined idea that could be strategically adapted to appeal to diverse constituencies. We discuss the theoretical implications of this finding for the ‘Advocacy Coalition Framework’, as well as the practical implications of the findings for efforts to promote ‘transparency’ and public health in the EU.",
    keywords = "better regulation, tobacco industry, corporate policy influence, evidence, British American Tobacco (BAT), policy, industry regulation",
    author = "Smith, {Katherine Elizabeth} and Gary Fooks and Gilmore, {Anna B.} and Jeffrey Collin and Heide Weishaar",
    year = "2015",
    month = "4",
    day = "1",
    doi = "10.1215/03616878-2882231",
    language = "English",
    volume = "40",
    pages = "325--372",
    journal = "Journal of Health Politics, Policy and Law",
    issn = "0361-6878",
    number = "2",

    }

    Corporate coalitions and policy making in the European Union. / Smith, Katherine Elizabeth; Fooks, Gary; Gilmore, Anna B.; Collin, Jeffrey; Weishaar, Heide.

    In: Journal of Health Politics, Policy and Law , Vol. 40, No. 2, 01.04.2015, p. 325-372.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Corporate coalitions and policy making in the European Union

    AU - Smith, Katherine Elizabeth

    AU - Fooks, Gary

    AU - Gilmore, Anna B.

    AU - Collin, Jeffrey

    AU - Weishaar, Heide

    PY - 2015/4/1

    Y1 - 2015/4/1

    N2 - Over the past fifteen years, an inter-connected set of regulatory reforms, known as Better Regulation, has been adopted across Europe, marking a significant shift in the way European Union (EU) policies are developed. There has been little exploration of the origins of these reforms, which include mandatory ex-ante impact assessment. Drawing on documentary and interview data, this paper discusses how and why large corporations, notably British American Tobacco (BAT), worked to influence and promote these reforms. Our analysis highlights: (i) how policy entrepreneurs with sufficient resources (such as large corporations) can shape the membership and direction of advocacy coalitions; (ii) the extent to which ‘think tanks’ may be prepared to lobby on behalf of commercial clients; and (iii) why regulated industries (including tobacco) may favour the use of ‘evidence-tools’, such as impact assessments, in policymaking. We argue a key aspect of BAT’s ability to shape regulatory reform involved the deliberate construction of a vaguely defined idea that could be strategically adapted to appeal to diverse constituencies. We discuss the theoretical implications of this finding for the ‘Advocacy Coalition Framework’, as well as the practical implications of the findings for efforts to promote ‘transparency’ and public health in the EU.

    AB - Over the past fifteen years, an inter-connected set of regulatory reforms, known as Better Regulation, has been adopted across Europe, marking a significant shift in the way European Union (EU) policies are developed. There has been little exploration of the origins of these reforms, which include mandatory ex-ante impact assessment. Drawing on documentary and interview data, this paper discusses how and why large corporations, notably British American Tobacco (BAT), worked to influence and promote these reforms. Our analysis highlights: (i) how policy entrepreneurs with sufficient resources (such as large corporations) can shape the membership and direction of advocacy coalitions; (ii) the extent to which ‘think tanks’ may be prepared to lobby on behalf of commercial clients; and (iii) why regulated industries (including tobacco) may favour the use of ‘evidence-tools’, such as impact assessments, in policymaking. We argue a key aspect of BAT’s ability to shape regulatory reform involved the deliberate construction of a vaguely defined idea that could be strategically adapted to appeal to diverse constituencies. We discuss the theoretical implications of this finding for the ‘Advocacy Coalition Framework’, as well as the practical implications of the findings for efforts to promote ‘transparency’ and public health in the EU.

    KW - better regulation

    KW - tobacco industry

    KW - corporate policy influence

    KW - evidence

    KW - British American Tobacco (BAT)

    KW - policy

    KW - industry regulation

    U2 - 10.1215/03616878-2882231

    DO - 10.1215/03616878-2882231

    M3 - Article

    VL - 40

    SP - 325

    EP - 372

    JO - Journal of Health Politics, Policy and Law

    T2 - Journal of Health Politics, Policy and Law

    JF - Journal of Health Politics, Policy and Law

    SN - 0361-6878

    IS - 2

    ER -